Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.00 $3.50 Thursday, 9th May 2024 MYMD stock ended at $2.53. This is 7.33% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.51% from a day low at $2.53 to a day high of $2.72.
90 days $0.110 $3.84
52 weeks $0.110 $3.84

Historical MyMD Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
May 22, 2019 $34.27 $34.56 $33.12 $33.12 1 116
May 21, 2019 $34.56 $36.34 $33.60 $33.84 1 469
May 20, 2019 $35.04 $36.00 $34.08 $34.66 1 503
May 17, 2019 $35.09 $36.48 $34.08 $35.57 2 266
May 16, 2019 $35.57 $37.73 $35.09 $36.00 2 299
May 15, 2019 $32.88 $41.28 $32.88 $36.10 13 526
May 14, 2019 $32.21 $33.36 $31.68 $32.98 2 040
May 13, 2019 $33.60 $33.60 $31.68 $33.22 3 155
May 10, 2019 $35.95 $36.48 $33.12 $33.98 3 404
May 09, 2019 $38.40 $38.40 $34.70 $34.99 1 955
May 08, 2019 $38.88 $38.98 $36.48 $36.58 2 349
May 07, 2019 $38.88 $39.02 $37.44 $38.69 1 253
May 06, 2019 $39.84 $39.84 $38.40 $38.40 1 962
May 03, 2019 $39.26 $40.32 $39.26 $39.26 1 546
May 02, 2019 $39.41 $40.80 $38.88 $38.88 1 093
May 01, 2019 $38.40 $39.84 $38.40 $39.41 1 545
Apr 30, 2019 $39.55 $41.28 $39.36 $39.36 1 079
Apr 29, 2019 $41.28 $41.28 $38.40 $41.28 4 043
Apr 26, 2019 $19.44 $21.36 $19.20 $20.71 7 864
Click to get the best stock tips daily for free!

About MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals. MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as t... MYMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT